Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

57.1%

4 terminated/withdrawn out of 7 trials

Success Rate

20.0%

-66.5% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

4 withdrawn

Enrollment Performance

Analytics

Phase 3

3(60.0%)

Phase 4

1(20.0%)

N/A

1(20.0%)

5Total

Phase 3(3)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06944405Not ApplicableNot Yet Recruiting

Implementation for Heart Failure Therapies Post-discharge Followed by CardiOSIgnal at HOME

Role: collaborator

NCT05244343Completed

I VACCIN Hospitalization of COVID-19 Patients

Role: lead

NCT04351919Phase 4Withdrawn

Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)

Role: collaborator

NCT04349228Phase 3Withdrawn

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals

Role: collaborator

NCT04384614Withdrawn

Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study

Role: collaborator

NCT04361032Phase 3Unknown

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia

Role: collaborator

NCT04528927Phase 3Withdrawn

Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia

Role: collaborator

All 7 trials loaded